-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ICAt/1F1yF7pncLF9KgQKFxusRv/GUXXvjYESTFiSrXZNZj63eyD1U1aStSh8Z0C PP9HyXnnM7lFfIwcTGyegg== 0000885590-10-000048.txt : 20100930 0000885590-10-000048.hdr.sgml : 20100930 20100930214835 ACCESSION NUMBER: 0000885590-10-000048 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100928 FILED AS OF DATE: 20100930 DATE AS OF CHANGE: 20100930 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pearson J. Michael CENTRAL INDEX KEY: 0001426004 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14956 FILM NUMBER: 101100503 MAIL ADDRESS: STREET 1: ONE ENTERPRISE CITY: ALISO VIEJO STATE: CA ZIP: 92656 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Valeant Pharmaceuticals International, Inc. CENTRAL INDEX KEY: 0000885590 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7150 MISSISSAUGA ROAD STREET 2: MISSISSAUGA CITY: ONTARIO STATE: A6 ZIP: 00000 BUSINESS PHONE: 905 286-3000 MAIL ADDRESS: STREET 1: 7150 MISSISSAUGA ROAD STREET 2: MISSISSAUGA CITY: ONTARIO STATE: A6 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL Corp DATE OF NAME CHANGE: 20100416 FORMER COMPANY: FORMER CONFORMED NAME: BIOVAIL CORP INTERNATIONAL DATE OF NAME CHANGE: 19960522 4 1 primary_doc.xml PRIMARY DOCUMENT X0303 4 2010-09-28 0 0000885590 Valeant Pharmaceuticals International, Inc. VRX 0001426004 Pearson J. Michael 7150 MISSISSAUGA ROAD MISSISSAUGA A6 L5N 8M5 ONTARIO, CANADA 1 1 0 0 Chief Executive Officer Common Stock, no par value 2010-09-28 4 A 0 2909776 0 A 2909776 D Common 2010-09-28 4 A 0 1665410 0 A 4575186 D Non-Qualified Stock Options (right to purchase) 4.36 2010-09-28 4 A 0 2866593 4.36 A 2018-02-01 Common Stock, no par value 2866593 2866593 D Non-Qualified Stock Options (right to purchase) 13.37 2010-09-28 4 A 0 1398896 13.37 A 2019-12-01 Common Stock, no par value 1398896 1398896 D The stock options were initially granted on February 1, 2008, half of which have vested. The stock options were initially granted on December 1, 2009 and have not yet vested. Represents long-term performance units (the "Performance Units") received upon conversion of the reporting person's Valeant Pharmaceuticals International ("old Valeant") Performance Units that were held prior to the merger between the issuer (formerly known as Biovail Corporation) and old Valeant (the "Merger"), in accordance with the terms of the Merger agreement between the issuer and, amongst others, old Valeant. The Performance Units can be settled only in common shares of the issuer. The fair market value of old Valeant on the day prior to the effective date of the Merger was $63.25 per share. Represents restricted share units received upon conversion of the reporting person's old Valeant restricted stock units that were held prior to the Merger. The restricted share units can be settled only in common shares of the issuer. The fair market value of old Valeant on the day prior to the effective date of the Merger was $63.25 per share. By: Angie Palmer For: J. Michael Pearson 2010-09-30 -----END PRIVACY-ENHANCED MESSAGE-----